<!DOCTYPE html>
<html lang="en"><head>
<script src="amyloidosis_files/libs/clipboard/clipboard.min.js"></script>
<script src="amyloidosis_files/libs/quarto-html/tabby.min.js"></script>
<script src="amyloidosis_files/libs/quarto-html/popper.min.js"></script>
<script src="amyloidosis_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="amyloidosis_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="amyloidosis_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="amyloidosis_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="amyloidosis_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.450">

  <meta name="author" content="Serdar BalcÄ±">
  <title>Amyloidosis</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="amyloidosis_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="amyloidosis_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="amyloidosis_files/libs/revealjs/dist/theme/quarto.css">
  <link href="amyloidosis_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="amyloidosis_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="amyloidosis_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="amyloidosis_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAEU0lEQVRYCcVXTWhcVRQ+586kSUMMxkyaElstCto2SIhitS5Ek8xUKV2poatCcVHtUlFQk8mbaaziwpWgglJwVaquitBOfhQXFlqlzSJpFSpIYyXNjBNiTCck7x2/8/LeNDOZxDuEkgOXe++553zfefee+/OYLOXFk3+1LLrRdiO81yNqZ6K9cG0P3MeFaMIQjXssE8Z1JzLO9ls20MBZX7oG8w9GxB0goaPrW5aNMp1yOZIa7Wv6o2ykpLtmAPs/vrG14Z+6d4jpbSKuhdcSyq9wGMPXjonwmESXrriLzFGOdDBLB8Y6MNYBu0dRokSygMA/mrun8MGFN3behm6VVAwg4WR3i6FvYK1T7MHo9BK7ydH+1uurECoouk5MPRyVSBrBHMYwVobG2aOXM07sWrn5qgB60rc6mcwIDJtQrnrEr44kmy+UO9r0u9O5/YbkS9juQckLed3DyW2XV/qWBBB3ptvI8EUY3I9p/67OW+g967TNr3Sotn3IuVlfMLVnsBwH4fsnebJvyGm5GeIUA3jljERmrv49SizPYuq+z7c2H/jlGC+Ghhupn/hcapqmcudB9jwJ/3jvnvu6vu5lVzF1fXyZuZZ7U8nRmVzytvT+H3kilYvH09mLWrQdwFSsFEsxFVs5fK7A0g8gMZjbif4ACpKbjv7gNGaD8bUrlk8x+KRflttr22JEMRUbTUwwDQScyzPgedQHZT0xnx7ujw2jfVfExwYHwOsDTjLdJ2ebmeQIlJ7neo41s/DrsL3kl+W2lWvAga0tR3zueGr6GL78M3ifH0rGXrBC2aAR8uYcIA5gwV8zIE8onoh8u0Fca/ciF7j1uOzEnqcIm59sEXoGc0+z6+H45V1CvAvHcD7THztu669cnp+L0okAeIc6zjbM/24LgGM1gZk7jnRu1aQWoU9sfUOuhrmtaPIO3YY1KLLWZaEO5TKUbMY5zx8W9UJ6elpLwKXbsaZ4EFl7B4bMtDv0iRipKoDQT2sNQI9b1utXFdYisi+wzZ/ri/1m7QfDgEuvgUUEIJPq3DhX/5DWNqIXDOweC2wvIR90Oq3lDpdMIgD2r0dXvGdsEW5H6x6HLRJYU7C69VefO1x8Gde1ZFSJLfWS1jbCnhtOPxmpfv2LXOA2Xk2tvnwKKPFuZ/oRmwBwqRQDcKNeVQkYcOjtWVBuM/JuYw5b6isojIkYxyYAFn5K7ZBF10fea52y8QltAg6jnMqNHFBmGkQ1j+U43HMi2xMar1Nv0zGsf1s8nUsmUtPOOrbFIR8bHFDMB5zL13Gmr/kGlCkUzedTzzmzsaJXhYawnA3UmARpiYj5ooJZiUoxFRtK3X6pgNPv+IZVPcnwbOl6f+aBaO1CNvPW9n9LmCp01nuSaTRF2YxHqZ8DYQT6WsXT+RD6eUztwYLZ8rM+rcPxamv1VQzFUkzFXvkiVrySGQgJNvXHJAxiU3/NwiC03rSf05VBaPtu/Z7/B8Yn/w7eguloAAAAAElFTkSuQmCC');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAEKklEQVRYCcVXTWhcVRS+575MJym48A+hSRFr00ySRQhURRfd2HYjk2SSTokuBCkU2o0LoSKKraKIBTcuFCoidGFD08nkBzdREbpQ1EDNIv8qSGMFUboImMSZd4/f9zJv8ibJMC8xJQfO3HPPPef7zrvvvnvviIkpC9nsw0UttFunbUhpFzFtarSd6WJkStVMw5xyVqYTvkwfzuf/5FgtkVoB0729j1rjXwThS7Vio+Mo6DNnvLfahoZ+i/o32lULuJ3NNiz7q6+pyAUkJaFF6JwaM2lUJlV0MlnQn5aTRbEu0SEqHUa0A4AdiGuB1kFXRfVyg5d87+Dg4DL6m2TLAub60ilj7A1Ec4odSAc8X95sHh7+ZRPCFo6Fnp7HfU/fBng/hi10CjCnWnJjsxvDNxWw0NfV6Rv5GgP3I3jGWXumdTD/3cbEOP2ZbOZp69yniG3FQ9z1jD7bnBu9Fc2tKGC2q+uAJOQHBDRiZX1x36o7fWBs7J9ownbtO+n0/qWkvW7UPIfc37WgT6ZGR++EOJyeQDSb9UB+DZ1G6DdLDzyS+b/kBCYGsYgJbSQHuThGKRcw5xdeQf8YdNHsc6ePXrlSYMBuSIAFTGAtQo+VuALo4BX83N190NWZWbynBjhOHsmNfFWLeL6v+ynsA58zDvvAC8j5PkbOcXCMg2PZFk3q8MjI7WAG/Dp9AwP7jdGBOOQkAvlFUB+irtm16I1Zw9YBcpGTGXYmk3kQIC/Cds55l+iMI3jqhjAuaoe+am2Jw5GT3Nbz3CkE12NavmzN5+erJW7046n/CH1RO/RVa8lBLozXk9uqykkGAyRXLWlLv5jyp4RFsG5vGVzpDLnIjTWgnRy2Rr+tDKvRc7Y8AyZq10jj8DqXdnIRNtFZb+t/ZRtXcDiVnzpqx8mPcDWxgARUqx0W1QB9MeUZiNrV4qP+Ehc+BpNgATsTX8ozYKL2NtFYAHc84fG7ndxUPr+AR/iQSns7uSUufAymwDOb2+NjK27lEFocm/EE2WpyIy/Hi66MWuMKJn8RvxIcj87IM5Vh9663ziW36kR0HNenXuxmfaD8JC7tfKbrhFr7LiZCrMjrzTeGx+PmkosrkNzW94ObzwocJ7A1HokLolY+AvkTiD/q1H0cN48c5EL8Crkttsa/AXQVDmutfyku0E7jShx49XqV3MFK8IryDhYVbj7Sj2P2eBxwcXoe8T8idsKKPRcnZw1b+slFTubwUwhktrfnAt7J++jwQtLZcm3sr9LQrjRzz6cfMv9aLvgmnAGvpoaGLxM4mAEaLV7iAzQ3oU0IvD5x9ix3yF2RAAuYAOO2f7PEFWCXZ4C9Pb2UsgDeVnFSpbFK7/IWu7TPTvBqzbGdCHOJQSxiEjt6IyZmxQyEJHv6xyQsYk//moVFsN2zP6fRImjfq7/n/wFDguUQFNEwugAAAABJRU5ErkJggg==');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Amyloidosis</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar BalcÄ± 
</div>
</div>
</div>

</section>
<section class="slide level2">


<img data-src="./img-local/Amyloidosispptx-sunum0.jpg" class="r-stretch"></section>
<section id="amyloidosis" class="slide level2">
<h2>Amyloidosis</h2>
</section>
<section id="serdar-balci-md" class="slide level2">
<h2>Serdar BALCI, MD</h2>
</section>
<section id="amyloidosis-1" class="slide level2">
<h2>Amyloidosis</h2>
<ul>
<li><strong>Deposit, accumulation of fibrillar proteins</strong></li>
<li><strong>Causes are many inherited and inflammatory disorders</strong></li>
<li><strong>Extracellular deposits of fibrillar proteins</strong>
<ul>
<li><strong>responsible for tissue damage and functional compromise</strong></li>
<li><strong>Misfolded proteins or protein fragments, normally soluble accumulate</strong>
<ul>
<li><strong>Abnormal fibrils</strong></li>
</ul></li>
</ul></li>
</ul>
<p><img data-src="./img-local/Amyloidosispptx-sunum1.png"></p>
<p><strong>Right conjunctival amyloidosis.</strong></p>
<p><strong>Al-Ola Abdallah, et al. Am J Case Rep. 2012;13:102-105.</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum2.png"></p>
<p><strong>Systemic AL amyloidosis</strong></p>
<p><strong>Estelle Desport, et al. Orphanet J Rare Dis. 2012;7:54-54.</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum3.png"></p>
<p><strong>Macroglossia due to amyloidosis</strong></p>
<p><strong>Hakan Emmungil, et al. Case Rep Rheumatol. 2014;2014:549641.</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum4.png"></p>
<p><strong>A patient with macroglossia</strong></p>
<p><strong>Gavin M. Melmed. Proc (Bayl Univ Med Cent). 2009 July;22(3):280-283.</strong></p>
</section>
<section id="amyloid-amylose-starch-like" class="slide level2">
<h2>Amyloid: Amylose (starch) like</h2>
<ul>
<li><strong>The fibrillar deposits bind</strong>
<ul>
<li><strong>proteoglycans and glycosaminoglycans</strong></li>
<li><strong>heparan sulfate and dermatan sulfate</strong></li>
<li><strong>plasma proteins</strong></li>
<li><strong>serum amyloid P component (SAP)</strong></li>
</ul></li>
<li><strong>These charged sugar groups cause staining characteristics resemble starch â That is why they are called amyloid</strong></li>
</ul>
</section>
<section id="pathogenesis-of-amyloid-deposition" class="slide level2">
<h2>PATHOGENESIS OF AMYLOID DEPOSITION</h2>
</section>
<section id="amyloid" class="slide level2">
<h2>Amyloid</h2>
<ul>
<li><strong>A disorder of protein misfolding</strong></li>
<li><strong>Not a structurally homogeneous protein</strong>
<ul>
<li><strong>more than 25 different protein</strong></li>
</ul></li>
<li><strong>But has same morphologic appearance</strong>
<ul>
<li><strong>Composed of nonbranching fibrils</strong></li>
<li><strong>7.5 to 10 nm in diameter</strong></li>
<li><strong>Formed of Î²-sheet polypeptide chains</strong></li>
<li><strong>Congo red stain binds to these fibrils and produces a redâgreen birefringence</strong></li>
</ul></li>
</ul>

<img data-src="./img-local/Amyloidosispptx-sunum5.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="amyloidosis-2" class="slide level2">
<h2>Amyloidosis</h2>
<ul>
<li><strong>Normally misfolded proteins are removed from body</strong>
<ul>
<li><strong>Intracellular, proteasomes</strong></li>
<li><strong>Extracellular, macrophages</strong></li>
</ul></li>
<li><strong>Misfolded proteins</strong>
<ul>
<li><strong>Unstable</strong></li>
<li><strong>Self-associate</strong></li>
<li><strong>Form oligomers and fibrils</strong></li>
<li><strong>Accumulate in tissues</strong></li>
</ul></li>
<li><strong>Disrupt normal function</strong></li>
</ul>
</section>
<section id="proteins-that-form-amyloid" class="slide level2">
<h2>Proteins that form amyloid</h2>
<ul>
<li><strong>Normal proteins</strong>
<ul>
<li><strong>when they are produced in increased amounts</strong></li>
<li><strong>tendency to fold improperly and associate to form fibrils</strong></li>
</ul></li>
<li><strong>Mutant proteins</strong>
<ul>
<li><strong>prone to misfolding</strong></li>
<li><strong>aggregation</strong></li>
</ul></li>
</ul>
<p><img data-src="./img-local/Amyloidosispptx-sunum6.jpg"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum7.png"></p>
<p><strong>Rubinâs Pathology 7th Ed</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum8.png"></p>
<p><strong>Rubinâs Pathology 7th Ed</strong></p>
</section>
<section id="al-amyloid-light-chain-protein" class="slide level2">
<h2>AL (amyloid light chain) protein</h2>
<ul>
<li><strong>Produced by plasma cells</strong></li>
<li><strong>Made up of</strong>
<ul>
<li><strong>Complete immunoglobulin light chains</strong></li>
<li><strong>The amino-terminal fragments of light chains</strong></li>
<li><strong>Both</strong></li>
</ul></li>
<li><strong>Monoclonal B cell proliferation</strong></li>
<li><strong>Defective degradation: some light chains are resistant to complete proteolysis</strong></li>
</ul>
</section>
<section id="aa-amyloid-associated-fibril" class="slide level2">
<h2>AA (amyloid-associated) fibril</h2>
<ul>
<li><strong>Pathogenesis:</strong>
<ul>
<li><strong>Long standing inflammation</strong></li>
<li><strong>IL-6, IL-1</strong></li>
<li><strong>SAA (serum amyloid-associated) protein synthesized by liver</strong></li>
<li><strong>Increased SAA levels</strong></li>
<li><strong>AA form of amyloid deposits</strong></li>
</ul></li>
<li><strong>Proposed mechanisms:</strong>
<ul>
<li><strong>An enzyme defect that results in incomplete breakdown of SAA â insoluble AA molecules</strong></li>
<li><strong>Genetically determined structural abnormality in the SAA molecule itself â resistant to degradation by macrophages</strong></li>
</ul></li>
</ul>
</section>
<section id="aÎ²-amyloid" class="slide level2">
<h2>AÎ² amyloid</h2>
<ul>
<li><strong>Cerebral lesions of Alzheimer disease</strong></li>
<li><strong>4-kDa peptide</strong></li>
<li><strong>The core of cerebral plaques</strong></li>
<li><strong>The core of amyloid deposits in cerebral blood vessels</strong></li>
<li><strong>Derived from</strong>
<ul>
<li><strong>Larger transmembrane glycoprotein</strong></li>
<li><strong>Amyloid precursor protein (APP)</strong></li>
</ul></li>
</ul>
<p><img data-src="./img-local/Amyloidosispptx-sunum9.png"></p>
<p><strong>Rubinâs Pathology 7th Ed</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum10.png"></p>
<p><strong>Color Atlas of Pathology</strong></p>
</section>
<section id="transthyretin-ttr" class="slide level2">
<h2>Transthyretin (TTR)</h2>
<ul>
<li><strong>A normal serum protein that binds and transports thyroxine and retinol</strong></li>
<li><strong>Mutations in the gene alter its structure</strong>
<ul>
<li><strong>Misfolding</strong></li>
<li><strong>Aggregation</strong></li>
<li><strong>Resistant to proteolysis</strong></li>
<li><strong>Familial amyloid polyneuropathies</strong></li>
</ul></li>
<li><strong>Senile systemic amyloidosis</strong>
<ul>
<li><strong>Heart of aged persons</strong></li>
<li><strong>Protein is structurally normal</strong></li>
<li><strong>Accumulates at high concentrations</strong></li>
</ul></li>
</ul>
</section>
<section id="Î²2-microglobulin" class="slide level2">
<h2>Î²2-Microglobulin</h2>
<ul>
<li><strong>MHC class I molecule, normal serum protein</strong></li>
<li><strong>AÎ²2m fibers are structurally similar to normal Î²2m protein</strong></li>
<li><strong>Long-term hemodialysis</strong>
<ul>
<li><strong>Present in high concentrations in renal disease</strong></li>
<li><strong>Not efficiently filtered through dialysis membranes</strong></li>
<li><strong>Retained in the circulation</strong></li>
</ul></li>
<li><strong>60-80% of patients on long-term dialysis developed amyloid deposits</strong>
<ul>
<li><strong>Synovium</strong></li>
<li><strong>Joints</strong></li>
<li><strong>Tendon sheaths</strong></li>
</ul></li>
</ul>
</section>
<section id="other-proteins" class="slide level2">
<h2>Other proteins</h2>
<p><strong>Procalcitonin</strong></p>
<p><strong>Keratin</strong></p>
<p><strong>Prolactin</strong></p>
</section>
<section id="classification-of-amyloidosis" class="slide level2">
<h2>CLASSIFICATION OF AMYLOIDOSIS</h2>
<p><img data-src="./img-local/Amyloidosispptx-sunum11.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum12.png"></p>
</section>
<section id="primary-amyloidosis-immunocyte-dyscrasias-with-amyloidosis" class="slide level2">
<h2>Primary Amyloidosis: Immunocyte Dyscrasias with Amyloidosis</h2>
<ul>
<li><strong>Systemic</strong></li>
<li><strong>AL type</strong></li>
<li><strong>most common</strong></li>
<li><strong>Monoclonal plasma proliferation</strong></li>
<li><strong>5-15% multiple myeloma</strong></li>
<li><strong>Malignant Plasma Cells</strong>
<ul>
<li><strong>synthesize single Ig (monoclonal gammopathy)</strong>
<ul>
<li><strong>protein spike on serum electrophoresis</strong></li>
</ul></li>
<li><strong>synthesize or secrete Î» or Îº light chain</strong>
<ul>
<li><strong>Bence Jones protein</strong></li>
<li><strong>excreted in urine</strong></li>
</ul></li>
</ul></li>
</ul>
</section>
<section id="primary-amyloidosis-no-other-disease-found" class="slide level2">
<h2>Primary Amyloidosis: No other disease found</h2>
<p><strong>Have increased plasma cells in bone marrow</strong></p>
<p><strong>Not enough to cause tumor but increased light chain in serum or urine</strong></p>
</section>
<section id="reactive-systemic-amyloidosis-secondary-amyloidosis" class="slide level2">
<h2>Reactive Systemic Amyloidosis (Secondary amyloidosis)</h2>
<ul>
<li><strong>Systemic</strong></li>
<li><strong>AA protein</strong></li>
<li><strong>Secondary to an associated inflammatory condition</strong></li>
<li><strong>Chronic inflammation</strong>
<ul>
<li><strong>Tuberculosis</strong></li>
<li><strong>Bronchiectasis</strong></li>
<li><strong>Chronic osteomyelitis</strong></li>
<li><strong>Autoimmune disease</strong>
<ul>
<li><strong>RA</strong></li>
<li><strong>Ankylosing spondylitis</strong></li>
<li><strong>Inflammatory bowel disease</strong></li>
</ul></li>
<li><strong>Chronic skin infections</strong>
<ul>
<li><strong>âskin-poppingâ of narcotics</strong></li>
</ul></li>
</ul></li>
<li><strong>Tumors</strong>
<ul>
<li><strong>Renal cell carcinoma</strong></li>
<li><strong>Hodgkin lymphoma</strong></li>
</ul></li>
</ul>
</section>
<section id="familial-hereditary-amyloidosis-familial-mediterranean-fever-fmf" class="slide level2">
<h2>Familial (Hereditary) AmyloidosisFamilial Mediterranean Fever (FMF)</h2>
<ul>
<li><strong>AA proteins</strong></li>
<li><strong>Autosomal recessive</strong></li>
<li><strong>Attacks of fever</strong></li>
<li><strong>Inflammation of serosal surfaces</strong></li>
<li><strong>Peritoneum, pleura, and synovial membrane</strong></li>
<li><strong>Seen in</strong>
<ul>
<li><strong>Turkey</strong></li>
<li><strong>Armenian</strong></li>
<li><strong>Sephardic Jewish</strong></li>
<li><strong>Arabic</strong></li>
</ul></li>
</ul>
<p><strong>Gene â pyrin</strong></p>
<p><strong>Protein â component of the inflammasome</strong></p>
<p><strong>Patients have gain-of-function mutations in pyrin â constitutive overproduction of the pro-inflammatory cytokine IL-1 â Persistent inflammation</strong></p>
</section>
<section id="familial-hereditary-amyloidosis-familial-amyloidotic-polyneuropathies" class="slide level2">
<h2>Familial (Hereditary) AmyloidosisFamilial Amyloidotic Polyneuropathies</h2>
<p><strong>Peripheral and autonomic nerves</strong></p>
<p><strong>In different parts of the world</strong></p>
<p><strong>Portugal, Japan, Sweden, United States</strong></p>
<p><strong>Mutant forms of transthyretin (ATTRs)</strong></p>
</section>
<section id="hemodialysis-associated-amyloidosis" class="slide level2">
<h2>Hemodialysis-Associated Amyloidosis</h2>
<p><strong>Long-term hemodialysis for renal failure</strong></p>
<p><strong>Deposition of Î²</strong> <strong>2</strong> <strong>-microglobulin</strong></p>
<p><strong>Could not be filtered and accumulates</strong></p>
<p><strong>Carpal Tunnel Syndrome</strong></p>
<p><strong>New membranes are told to filter these proteins as well</strong></p>
</section>
<section id="localized-amyloidosis" class="slide level2">
<h2>Localized Amyloidosis</h2>
<ul>
<li><strong>Limited to a single organ or tissue</strong></li>
<li><strong>Detectable nodular masses or microscopic</strong></li>
<li><strong>Nodular (tumor-forming) deposits</strong>
<ul>
<li><strong>Lung, larynx, skin, urinary bladder, tongue, eye</strong></li>
</ul></li>
<li><strong>Infiltrates of lymphocytes and plasma cells in the periphery</strong>
<ul>
<li><strong>Is it a response or are they responsible for it?</strong></li>
</ul></li>
</ul>
</section>
<section id="endocrine-amyloid" class="slide level2">
<h2>Endocrine Amyloid</h2>
<ul>
<li><strong>Endocrine tumors</strong>
<ul>
<li><strong>Medullary carcinoma of the thyroid gland</strong>
<ul>
<li><strong>polypeptide hormones</strong></li>
</ul></li>
<li><strong>Islet tumors of the pancreas</strong>
<ul>
<li><strong>islet amyloid polypeptide</strong></li>
</ul></li>
<li><strong>Pheochromocytoma</strong></li>
<li><strong>Undifferentiated carcinomas of the stomach</strong></li>
</ul></li>
<li><strong>Islets of Langerhans, type 2 diabetes mellitus</strong></li>
</ul>
<p><img data-src="./img-local/Amyloidosispptx-sunum13.png"></p>
<p><strong>Color Atlas of Pathology</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum14.png"></p>
<p><strong>Medullary carcinoma of thyroid</strong></p>
<p><strong>Color Atlas of Pathology</strong></p>
</section>
<section id="amyloid-of-aging" class="slide level2">
<h2>Amyloid of Aging</h2>
<ul>
<li><strong>Senile systemic amyloidosis</strong>
<ul>
<li><strong>Systemic deposition of amyloid in elderly (70s-80s)</strong></li>
<li><strong>Heart (senile cardiac amyloidosis)</strong>
<ul>
<li><strong>Restrictive cardiomyopathy</strong></li>
<li><strong>Arrhythmias</strong></li>
<li><strong>Normal transthyretin</strong></li>
</ul></li>
</ul></li>
<li><strong>Mutant form of TTR</strong>
<ul>
<li><strong>Typically affecting only the heart</strong></li>
<li><strong>4% of the black population United States are carriers of the mutant allele</strong></li>
<li><strong>cardiomyopathy identified in both homozygous and heterozygous</strong></li>
</ul></li>
</ul>
</section>
<section id="morphology-of-amyloidosis" class="slide level2">
<h2>MORPHOLOGY OF AMYLOIDOSIS</h2>
</section>
<section id="morphology-of-amyloidosis-1" class="slide level2">
<h2>Morphology of Amyloidosis</h2>
<ul>
<li><strong>Small amounts are recognized with iodine and sulfuric acid</strong>
<ul>
<li><strong>Reddish (mahogany) brown staining of the amyloid deposits</strong></li>
</ul></li>
<li><strong>Larger amounts</strong>
<ul>
<li><strong>Organ is enlarged</strong></li>
<li><strong>Tissue appears gray with a waxy, firm consistency</strong></li>
</ul></li>
<li><strong>Histologic examination</strong>
<ul>
<li><strong>Amyloid deposition is always extracellular and begins between cells</strong></li>
<li><strong>Often closely adjacent to basement membranes</strong></li>
<li><strong>As amyloid accumulates, it grows over, surround and destroy the cells</strong></li>
<li><strong>AL form, perivascular and vascular localizations are common</strong></li>
</ul></li>
</ul>
</section>
<section id="methods-to-detect-amyloid" class="slide level2">
<h2>Methods to detect amyloid</h2>
<p><span style="color:##FB00A1">Eosinophilic </span> <strong>amorphous acellular material with H&amp;E</strong></p>
<p><strong>Weakly PAS positive (starch like)</strong></p>
<p><span style="color:##FF0000">Congo-Red: </span> <strong>Apple-green birefringence under polarized light</strong></p>
<p><span style="color:##3366FF">Crystal violet:</span> __ metachromatic staining__</p>
<p><strong>Electron Microscopy</strong></p>
<p><strong>Immunohistochemistry</strong></p>
<p><strong>Mass Spectrometry-Based Proteomic Analysis</strong></p>
<p><strong>Serum, urine electrophoresis</strong></p>
<p><strong>Genetic mutation analysis</strong></p>

<img data-src="./img-local/Amyloidosispptx-sunum15.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="congo-redstain-apple-green-birefringence-under-polarized-light" class="slide level2">
<h2>Congo redâstain: Apple-green birefringence under polarized light</h2>
<p><img data-src="./img-local/Amyloidosispptx-sunum16.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum17.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum18.png"></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum19.png"></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum20.png"></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum21.png"></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum22.png"></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum23.png"></p>
</section>
<section id="amyloid-in-kidney" class="slide level2">
<h2>Amyloid in Kidney</h2>
<ul>
<li><strong>Most common and most serious </strong></li>
<li><strong>Grossly</strong>
<ul>
<li><strong>Unchanged</strong></li>
<li><strong>Abnormally large, pale, gray, and firm</strong></li>
<li><strong>In long-standing cases, reduced in size</strong></li>
</ul></li>
<li><strong>Microscopically</strong>
<ul>
<li><strong>Glomeruli</strong>
<ul>
<li><strong>Focal deposits within the mesangial matrix</strong></li>
<li><strong>Diffuse or nodular thickenings of the basement membranes of the capillary loops</strong></li>
<li><strong>Grows over capillary lumina</strong></li>
<li><strong>Obliteration of the vascular tuft</strong></li>
</ul></li>
<li><strong>Interstitial peritubular tissue</strong>
<ul>
<li><strong>Amorphous pink casts within the tubular lumens</strong></li>
</ul></li>
<li><strong>Walls of the blood vessels</strong>
<ul>
<li><strong>Marked vascular narrowing</strong></li>
</ul></li>
</ul></li>
</ul>

<img data-src="./img-local/Amyloidosispptx-sunum24.png" class="r-stretch"><p><strong>Rubinâs Pathology 7th Ed</strong></p>
</section>
<section id="amyloid-in-spleen" class="slide level2">
<h2>Amyloid in Spleen</h2>
<p><strong>Moderate or even marked enlargement (200 to 800 gm)</strong></p>
<p><strong>Limited to the splenic follicles</strong></p>
<p><strong>Limited to splenic sinuses</strong></p>

<img data-src="./img-local/Amyloidosispptx-sunum25.png" class="r-stretch"><p><strong>Color Atlas of Pathology</strong></p>
</section>
<section id="amyloid-in-liver" class="slide level2">
<h2>Amyloid in Liver</h2>
<p><strong>Massive enlargement (9000)</strong></p>
<p><strong>Extremely pale, grayish, and waxy on both the external surface and the cut section</strong></p>
<p><strong>First appear in the space of Disse</strong></p>
<p><strong>Progressively enlarge to encroach on the adjacent hepatic parenchyma and sinusoids</strong></p>
<p><strong>Trapped liver cells undergo compression atrophy</strong></p>
<p><strong>Replaced by sheets of amyloid</strong></p>
<p><strong>Normal liver function may be preserved even in the setting of severe involvement</strong></p>

<img data-src="./img-local/Amyloidosispptx-sunum26.png" class="r-stretch"><p><strong>Rubinâs Pathology 7th Ed</strong></p>
</section>
<section id="heart" class="slide level2">
<h2>Heart</h2>
<p><strong>Systemic involvement</strong></p>
<p><strong>AL form</strong></p>
<p><strong>Isolated form (senile amyloidosis)</strong></p>
<p><strong>older persons</strong></p>
<p><strong>Normal grossly or minimal to moderate cardiac enlargement</strong></p>
<p><strong>Gray-pink, subendocardial elevations, in atrial chambers</strong></p>
<p><strong>Histologic examination</strong></p>
<p><strong>Deposits begin between myocardial fibers cause pressure atrophy</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum27.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="./img-local/Amyloidosispptx-sunum28.png"></p>
<p><strong>Rubinâs Pathology 7th Ed</strong></p>
</section>
<section id="other-organs" class="slide level2">
<h2>Other Organs</h2>
<ul>
<li><strong>Adrenals</strong></li>
<li><strong>Thyroid</strong></li>
<li><strong>Pituitary</strong></li>
<li><strong>Tongue may produce macroglossia</strong></li>
<li><strong>Gingival, intestinal, and rectal biopsies are useful in diagnosis</strong></li>
<li><strong>Abdominal fat aspirates are used for diagnosis</strong></li>
<li><strong>Î²2-microglobulin amyloid</strong>
<ul>
<li><strong>long-term dialysis</strong></li>
<li><strong>carpal ligaments of the wrist</strong></li>
<li><strong>compression of the median nerve (carpal tunnel syndrome)</strong></li>
</ul></li>
</ul>
</section>
<section id="clinical-course-of-amyloidosis" class="slide level2">
<h2>Clinical Course of Amyloidosis</h2>
<p><strong>Atrophy</strong></p>
<p><strong>Toxic to neighbour cells</strong></p>
<p><strong>Impair normal organ, tissue function</strong></p>
<p><strong>Depend on organ and severity of involvement</strong></p>
</section>
<section id="section" class="slide level2">
<h2></h2>
</section>
<section id="amyloid-1" class="slide level2">
<h2>Amyloid</h2>
<p><strong>Proteinaceous substance deposited between cells in various tissues and organs in a variety of clinical settings.</strong></p>
<p><strong>starchlike staining properties, PAS positive</strong></p>
<p><strong>Amorphous, eosinophilic, hyaline extracellular substance</strong></p>
<ul>
<li><strong>chemically diverse</strong></li>
<li><strong>typical physical properties:</strong>
<ul>
<li><strong>irrespective of their biochemical composition</strong></li>
<li><strong>form nonbranching long fibrils (7.5â10 mm)</strong></li>
<li><strong>By electron diffraction, they are arranged into b-pleated sheaths.</strong></li>
<li><strong>Congo red staining is typical</strong></li>
<li><strong>Under polarized light, Congo red-stained amyloid fibrils show an apple green birefringence.</strong></li>
</ul></li>
</ul>
</section>
<section id="amyloidosis-3" class="slide level2">
<h2>Amyloidosis</h2>
<ul>
<li><strong>group of diseases characterized by a deposition of amyloid in various organs</strong>
<ul>
<li><strong>as a primary disease</strong>
<ul>
<li><strong>in multiple myeloma</strong></li>
</ul></li>
<li><strong>Secondary</strong>
<ul>
<li><strong>during the course of chronic inflammatory or other diseases.</strong></li>
</ul></li>
<li><strong>may be limited (localized) to a single organ</strong></li>
<li><strong>may be systemic</strong></li>
<li><strong>may be hereditary</strong></li>
</ul></li>
</ul>
</section>
<section id="primary-amyloidosis" class="slide level2">
<h2>Primary amyloidosis</h2>
<p><strong>Systemic deposition of AL-type amyloid</strong></p>
<p><strong>Associated with plasma cell neoplasia and B-cell lymphoma</strong></p>
<p><strong>Monoclonal gammopathy (whole immunoglobulins or only light chains) found by electrophoresis of serum</strong></p>
</section>
<section id="secondary-systemic-amyloidosis" class="slide level2">
<h2>Secondary systemic amyloidosis</h2>
<ul>
<li><strong>Underlying disease</strong>
<ul>
<li><strong>tuberculosis, chronic osteomyelitis, rheumatoid arthritis, cancer</strong></li>
<li><strong>heroin abuse</strong></li>
</ul></li>
<li><strong>Widespread deposition of AA protein in many organs</strong></li>
</ul>
</section>
<section id="amyloidosis-of-aging" class="slide level2">
<h2>Amyloidosis of aging</h2>
<ul>
<li><strong>Systemic deposition of amyloid in elderly</strong></li>
<li><strong>Frequent involvement of the heart</strong>
<ul>
<li><strong>Cardiac amyloidosis</strong></li>
</ul></li>
</ul>
</section>
<section id="systemic-amyloidosis" class="slide level2">
<h2>Systemic amyloidosis</h2>
<ul>
<li><strong>Kidneys</strong>
<ul>
<li><strong>Both kidneys enlarged, pale, and waxy</strong></li>
<li><strong>Glomerular mesangial, interstitial, and vascular wall depositions</strong></li>
</ul></li>
<li><strong>Spleen</strong>
<ul>
<li><strong>Splenomegaly </strong></li>
<li><strong>nodular (follicular) depositions: sago spleen</strong></li>
<li><strong>maplike (red pulp) depositions: lardaceous spleen</strong></li>
</ul></li>
<li><strong>Liver</strong>
<ul>
<li><strong>Hepatomegaly</strong></li>
<li><strong>extracellular amyloid</strong></li>
<li><strong>pressure atrophy of hepatocytes</strong></li>
</ul></li>
<li><strong>Small blood vessels</strong></li>
<li><strong>Diagnosis may be made by biopsy of tissue</strong>
<ul>
<li><strong>fat pad, gingiva, or rectum</strong></li>
</ul></li>
</ul>
</section>
<section id="section-1" class="slide level2">
<h2></h2>
<p><strong>the traditional approaches to therapy focus on treating the underlying diseaseâspecifically, chemotherapy for myeloma (with AL amyloidosis) and antibiotics for chronic infections or anti- inflammatory agents for autoimmune diseases (with AA amyloidosis).</strong></p>
<p><strong>Some breakthroughs appear imminent, however: Building on an improved understanding of protein folding, research has led to production of a number of useful small moleculesâso-called âamyloid breakers,â now entering into clinical trial. Some of these interfere with the binding of chaperone proteins such as substance P and apolipoprotein E4 (apoE4), which can propagate the Î²-sheet content of AÎ² peptides and promote pathogenic fibril formation in the brain: CPHPC is a carboxypyrrolidinyl carboxylic acid derivative that binds to the P component and results in its prompt removal from the circulation thus eliminating an important ânucleation factorâ for amyloid propagation. Other agents such as tramiprosate inhibit the interactions between interstitial glycosaminoglycans and AÎ² that normally stabilize fibril formation; these breakers are sulfated glycosaminoglycan mimetics. Yet another approach is to stabilize native transthyretin tetramers with drugs like tafamadis or diflunisal to prevent the dissociation of monomeric components (e.g., from mutant isoforms) that can then misfold into amyloid fibrils.</strong></p>
<p><strong>With these approaches, coupled with earlier detection of amyloid deposits before irreversible damage is done, what previously has been an intractable and inexorable process may eventually become manageable.</strong></p>
</section>
<section id="references" class="slide level2">
<h2>References</h2>
<p><strong>Robbins Basic Pathology, 9</strong> <strong>th</strong> __ Ed, pp:__ <span style="color:##000000">153-154</span></p>
<p><strong>Pathology Secrets, 3</strong> <strong>rd</strong> __ ed, pp:74-75__</p>
<p><em><a href="http://www.mayomedicallaboratories.com/articles/hottopics/2009-12a-amyloidosis.html">http://www.mayomedicallaboratories.com/articles/hottopics/2009-12a-amyloidosis.html</a></em></p>
<p><strong>Rubinâs Pathology 7th Ed Clinicopathologic Foundations Of Medicine, pp: 563-573</strong></p>
<p><strong>Color Atlas of Pathology, pp:48-54</strong></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="amyloidosis_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="amyloidosis_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="amyloidosis_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="amyloidosis_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>